Clicky

House Select Subcommittee on the Coronavirus Crisis

House Select Subcommittee on the Coronavirus Crisis Welcome to the official account for the Select Subcommittee on the Coronavirus Crisis. Established by the U.S. And the lives of some kids. I don’t know how many.

House of Representatives on April 23, 2020, the Select Subcommittee on the Coronavirus Crisis is modeled after Senator Harry Truman’s Special Committee to Investigate the National Defense Program, which oversaw defense spending as the entire nation mobilized for World War II. As Senator Truman later observed:

"I knew that after the First World War there’d been a hundred and sixteen investigating

committees after the fact, and I felt that one committee before the fact would prevent a lot of waste and maybe even save some lives, and that’s the way it worked out. … I believe it was established that we saved the taxpayers about fifteen billion dollars. It was said ... some reporters estimated we may have saved the lives of a few thousand kids. The U.S. House of Representatives has charged the Select Subcommittee on the Coronavirus Crisis with examining:

(1) the efficiency, effectiveness, equity, and transparency of the use of taxpayer funds and relief programs to address the coronavirus crisis, including through Federal agencies, State and local government entities, financial institutions and other private businesses, contracts, grants, loans, loan guarantees, investments, cooperative agreements, or any other means;

(2) reports of waste, fraud, abuse, price gouging, profiteering, or other abusive practices related to the coronavirus crisis;

(3) the implementation or effectiveness of any Federal law applied, enacted, or under consideration to address the coronavirus crisis and prepare for future pandemics;

(4) preparedness for and response to the coronavirus crisis, including the planning for and implementation of testing, containment, mitigation, and surveillance activities; the acquisition, distribution, or stockpiling of protective equipment and medical supplies; and the development of vaccines and treatments;

(5) the economic impact of the coronavirus crisis on individuals, communities, small businesses, health care providers, States, and local government entities;

(6) any disparate impacts of the coronavirus crisis on different communities and populations, including with respect to race, ethnicity, age, s*x, gender identity, s*xual orientation, disability, and geographic region, and any measures taken to address such disparate impacts;

(7) executive branch policies, deliberations, decisions, activities, and internal and external communications related to the coronavirus crisis;

(8) the protection of whistleblowers who provide information about waste, fraud, abuse, or other improper activities related to the coronavirus crisis;

(9) cooperation by the executive branch and others with Congress, the Inspectors General, the Government Accountability Office, and others in connection with oversight of the preparedness for and response to the coronavirus crisis; and

(10) any other issues related to the coronavirus crisis.

Operating as usual

The Select Subcommittee has thoroughly investigated the effectiveness, efficiency, and equity of our nation’s COVID-19 r...
12/16/2022

The Select Subcommittee has thoroughly investigated the effectiveness, efficiency, and equity of our nation’s COVID-19 response. Our diligent work can help prevent and mitigate future public health and economic crises.

12/14/2022

BREAKING: House Select Subcommittee on the Coronavirus Crisis has formally adopted its final report into the congressional record, concluding over two years of investigations that identified at least $7B in questionable pandemic relief spending and increased transparency into the nation’s COVID-19 response.

Due to votes, the final hearing for the House Select Subcommittee on the Coronavirus Crisis on "Preparing For And Preven...
12/14/2022
Final Hearing | Preparing for and Preventing the Next Public Health Emergency

Due to votes, the final hearing for the House Select Subcommittee on the Coronavirus Crisis on "Preparing For And Preventing The Next Public Health Emergency: Lessons Learned From The Coronavirus Crisis" will begin at approximately 2:30pm ET.

On December 14, the Select Subcommittee will hold a final hearing to formally adopt the Select Subcommittee's final report and review the report's recommendations.

Tomorrow, Dr. Kizzmekia Corbett, Dr. Rick Bright, Dr. Ngozi Ezike and Rebecca Dixon will testify before the House Select...
12/13/2022
Final Hearing | Preparing for and Preventing the Next Public Health Emergency

Tomorrow, Dr. Kizzmekia Corbett, Dr. Rick Bright, Dr. Ngozi Ezike and Rebecca Dixon will testify before the House Select Subcommittee on the Coronavirus Crisis to review the coronavirus’ impacts and explore recommendations to prepare for and prevent future emergencies.

Tune in on December 14 at 2PM ET.

On December 14, the Select Subcommittee will hold a final hearing to formally adopt the Select Subcommittee's final report and review the report's recommendations.

BREAKING: House Select Subcommittee on the Coronavirus Crisis has just released its final report, which details findings...
12/09/2022
After two years of investigations, Select Subcommittee releases final report

BREAKING: House Select Subcommittee on the Coronavirus Crisis has just released its final report, which details findings from 2.5 years of investigative work. The report will be formally adopted on Wednesday, December 14.

Following a hearing on lessons learned from the pandemic, the report is to be adopted by Members at a business meeting on December 14.

Today, James E. Clyburn released the following statement on SBA's announcement that fintechs Blueacorn and Womply have b...
12/08/2022
Clyburn on SBA Action in Response to Select Subcommittee Fintech Report

Today, James E. Clyburn released the following statement on SBA's announcement that fintechs Blueacorn and Womply have been suspended from working with SBA in any capacity.

Chairman James Clyburn responds to SBA announcement that fintechs Blueacorn and Womply have been suspended from working with SBA in any capacity.

12/05/2022

Blueacorn and Womply received billons of $$ to screen PPP loans for fraud. Yet the two fintechs rewarded founders, friends and family with PPP loans—some of which had indicators of fraud—instead of investing in strong fraud controls.

In 2021, Blueacorn and Womply partners approved nearly one-third of over 6.68M PPP loans, despite concerning rates of potentially fraudulent applications.

Poor fraud controls at Blueacorn and Womply led to them becoming the companies of choice for gangs and fraudsters looking to defraud PPP.

The Select Subcommittee details these findings in its latest report.

Today, the House Select Subcommittee on the Coronavirus Crisis released a report detailing how certain fintechs tasked w...
12/01/2022
‘The more you submit, the more we get paid’: How fintech fueled covid aid fraud

Today, the House Select Subcommittee on the Coronavirus Crisis released a report detailing how certain fintechs tasked with delivering PPP funds to struggling small businesses likely disbursed tens of billions to ineligible or fraudulent applicants, while taking in billions in fees.

The probe by a congressional watchdog tasked to oversee roughly $5 trillion in federal covid aid contends there was rampant abuse among fintechs.

President Joe Biden is working to ensure Americans have access to vaccines and treatments that protect against COVID-19 ...
11/30/2022

President Joe Biden is working to ensure Americans have access to vaccines and treatments that protect against COVID-19 by encouraging pharmacies to partner with community organizations, improving outreach to communities of color, and providing Paxlovid prescription deliveries.

This month, House Select Subcommittee on the Coronavirus Crisis and Oversight Dems uncovered evidence detailing how IDme...
11/29/2022
House Dems say facial recognition company made 'baseless claims'

This month, House Select Subcommittee on the Coronavirus Crisis and Oversight Dems uncovered evidence detailing how IDme misrepresented COVID fraud estimates and downplayed excessive wait times for identity verifications as it sought additional business from the IRS.

The identity verification firm ID.me "inaccurately overstated" its capabilities to federal agencies, according to an investigation from the House Oversight committee.

11/22/2022

Last week, House Select Subcommittee on the Coronavirus Crisis and Oversight Dems revealed that IDme:

— Facial scans couldn’t verify 10-15% of people seeking unemployment benefits

— Had Americans in 14 states wait online an avg. of more than 4 hours to verify identity by video chat

— Baselessly claimed pandemic UI fraud was over $400B

Today, House Select Subcommittee on the Coronavirus Crisis and Oversight Dems reveal identity verification company IDme ...
11/17/2022
House Committees Slam ID.me for 'Baseless' Unemployment Fraud Claims

Today, House Select Subcommittee on the Coronavirus Crisis and Oversight Dems reveal identity verification company IDme downplayed excessive wait times and made baseless claims about the volume of pandemic UI fraud.

A seven month-long investigation accuses the biometric firm of providing misleading figures and subjecting unemployment seekers to "extraordinary wait times."

After investigation found that Equifax, Experian and TransUnion failed to adequately address credit report errors during...
11/14/2022
Clyburn praises new CFPB guidance after Select Subcommittee investigation

After investigation found that Equifax, Experian and TransUnion failed to adequately address credit report errors during the pandemic, House Select Subcommittee on the Coronavirus Crisis requested Consumer Financial Protection Bureau (CFPB) review.

Now, CFPB has issued guidance to improve dispute resolution.

The Select Subcommittee exposed inadequate dispute resolution practices by Equifax, Experian and TransUnion during the pandemic.

11/10/2022

The House Select Subcommittee on the Coronavirus Crisis continues to investigate potential acts of waste, fraud or abuse of pandemic relief funds intended to support American families, schools, small businesses, and public services during the COVID-19 pandemic.

The U.S. is one of the only countries without any form of national paid leave.Data obtained by the House Select Subcommi...
10/27/2022
The companies that won that war for talent during the Great Resignation had one major thing in common: they offered paid leave

The U.S. is one of the only countries without any form of national paid leave.

Data obtained by the House Select Subcommittee on the Coronavirus Crisis from twelve Fortune 500 companies reinforces existing research that paid leave can improve job retention rates—a win for both workers and employers.

A new report finds that workers who took paid leave got more raises and promotions, enticing them even more to stay.

NEW | House Select Subcommittee on the Coronavirus Crisis investigation of twelve Fortune 500 companies reveals workplac...
10/25/2022
Workers lacking paid leave quit at higher rates during pandemic, report shows

NEW | House Select Subcommittee on the Coronavirus Crisis investigation of twelve Fortune 500 companies reveals workplace inequities between hourly and salaried workers and along gender and racial/ethnic lines continued during the pandemic.

Democrats renew calls for universal paid sick leave in a new congressional report linking low wages and scant paid leave to heightened attrition and recruiting challenges during the pandemic.

Today, the House Select Subcommittee on the Coronavirus Crisis released a report detailing how the Trump Admin interfere...
10/17/2022
CDC officials describe intense pressure, job threats from Trump White House

Today, the House Select Subcommittee on the Coronavirus Crisis released a report detailing how the Trump Admin interfered with CDC's coronavirus response to help President Trump politically by downplaying the pandemic, manipulating guidance, and attacking scientists who shared accurate info.

Political infighting contributed to a sub-par pandemic response, says one official.

Yesterday, Chairman James E. Clyburn requested the Consumer Financial Protection Bureau (CFPB) review Equifax, Experian ...
10/14/2022
Select Subcommittee requests CFPB review Equifax, Experian, TransUnion

Yesterday, Chairman James E. Clyburn requested the Consumer Financial Protection Bureau (CFPB) review Equifax, Experian and TransUnion for potential violations of the Fair Credit Reporting Act after a House Select Subcommittee on the Coronavirus Crisis investigation found problems with the companies’ processes for addressing disputes.

The Select Subcommittee requested CFPB review the top three credit bureaus for potential violations of the Fair Credit Reporting Act after finding failures to address credit report errors.

10/04/2022

COVID-19 did not create the staffing shortages impacting nursing homes. But the virus did worsen them.

Corporate nursing homes should invest in expanding their workforces and giving them the resources necessary to provide quality care for residents.

A recent study shows Americans in communities exposed to high levels of air pollution—many of which are low-income or co...
10/03/2022
Improving air quality could reduce severe cases of COVID-19

A recent study shows Americans in communities exposed to high levels of air pollution—many of which are low-income or communities of color—faced greater risk of severe infection.

Cleaner air is critical to protecting public health.

Improving air quality could reduce severe cases of COVID-19 • Earth.com

NEW | House Select Subcommittee on the Coronavirus Crisis releases evidence of severe understaffing, poor PPE resourcing...
09/21/2022
New evidence of dire conditions at corporate nursing homes in 2020

NEW | House Select Subcommittee on the Coronavirus Crisis releases evidence of severe understaffing, poor PPE resourcing, and weak health protocols at many for-profit nursing home facilities early in the pandemic, which may have endangered residents and staff.

Documents obtained by Select Subcommittee shed light on conditions inside for-profit nursing home chains during the early months of the pandemic.

Tomorrow, nursing home experts, an advocate, and a frontline worker will testify before the House Select Subcommittee on...
09/20/2022
The Impact of the Coronavirus in Nursing Homes

Tomorrow, nursing home experts, an advocate, and a frontline worker will testify before the House Select Subcommittee on the Coronavirus Crisis to the unique challenges nursing home residents and staff faced during the COVID-19 pandemic.

Witnesses:

— Assistant Professor of Nursing Dr. Jasmine Travers (NYU Rory Meyers College of Nursing)
— Professor of Health Care Policy Dr. David C. Grabowski (Harvard Medical School)
— Senior Adviser for Aging and Chair of the Moving Forward Nursing Home Quality Coalition Dr. Alice Bonner (Institute for Healthcare Improvement - IHI)
— Nursing home CNA Adelina Ramos

Tune in on September 21 at 2PM ET.

On September 21, the Select Subcommittee examines the consequences of Covid and structural problems in nursing homes, as well as possible solutions to address them.

This week, the House Select Subcommittee on the Coronavirus Crisis will hear from nursing home experts, an advocate, and...
09/19/2022
The Impact of the Coronavirus in Nursing Homes

This week, the House Select Subcommittee on the Coronavirus Crisis will hear from nursing home experts, an advocate, and a frontline worker on the challenges posed to nursing home residents and staff during the coronavirus pandemic.

On September 21, the Select Subcommittee examines the consequences of Covid and structural problems in nursing homes, as well as possible solutions to address them.

Following recent pilot shortages, the House Select Subcommittee on the Coronavirus Crisis and Oversight Dems sent a lett...
09/15/2022
Clyburn, Maloney Request Treasury Review of Pandemic Aid for Airlines

Following recent pilot shortages, the House Select Subcommittee on the Coronavirus Crisis and Oversight Dems sent a letter to The U.S. Department of the Treasury Deputy IG to investigate how $60B in pandemic relief allocated to retain pilots was used by airlines.

In light of recent pilot shortages, Chairs Clyburn and Maloney request Treasury OIG to evaluate the use of pandemic relief funds by airlines to retain pilots and workers.

Today, Chairs James E. Clyburn and Rep. Carolyn B. Maloney asked the Treasury Inspector General to investigate airlines’...
09/09/2022
Two top House Democrats seek review of whether airlines used Covid bailout funds for staff buyouts

Today, Chairs James E. Clyburn and Rep. Carolyn B. Maloney asked the Treasury Inspector General to investigate airlines’ use of $60B in pandemic relief to potentially buyout and provide early retirement packages for pilots—which may be exacerbating a pilot shortage.

Two House Democrats asked the Treasury Department watchdog to review airlines' use of the more than $50 billion in aid for staff buyouts.

The Biden Administration is ensuring Americans have access to updated coronavirus boosters that target Omicron subvarian...
09/07/2022
Find COVID‑19 vaccine locations near you

The Biden Administration is ensuring Americans have access to updated coronavirus boosters that target Omicron subvariants and defend against severe outcomes from . Visit www.vaccines.gov to locate your nearest vaccine location.

Vaccines.gov helps you find clinics, pharmacies, and other locations that offer COVID‑19 vaccines in the United States.

The U.S. Food and Drug Administration and CDC have approved the first bivalent coronavirus boosters that target Omicron ...
09/01/2022
CDC recommends updated COVID vaccine boosters

The U.S. Food and Drug Administration and CDC have approved the first bivalent coronavirus boosters that target Omicron subvariants.

The boosters use the same technology as the 600 million mRNA doses already administered in the U.S. and will continue to protect Americans from severe outcomes.

A panel of U.S. health advisers voted to recommend Pfizer’s updated COVID-19 boosters that target the newest omicron strains for people 12 and older. The Centers for Disease Control and Prevention is expected to adopt the recommendation, the last step before shots can begin.

"FDA’s authorization of two bivalent coronavirus boosters will provide Americans an additional layer of protection again...
08/31/2022
Clyburn Statement on Updated Moderna, Pfizer Boosters

"FDA’s authorization of two bivalent coronavirus boosters will provide Americans an additional layer of protection against severe outcomes from COVID-19 and the Omicron BA.4 and BA.5 subvariants." — Chairman James E. Clyburn

Today, FDA authorized Moderna and Pfizer-BioNTech single dose bivalent coronavirus vaccines for use as a booster.

08/26/2022
Long Covid is Disproportionately Impacting Women

Millions of Americans are estimated to be experiencing Long COVID following a prior coronavirus infection. Research suggests women are more likely than men to face lasting coronavirus symptoms, which could impact job security and their wages.

Today, House Select Subcommittee on the Coronavirus Crisis reports Trump White House officials coordinated with known co...
08/24/2022
House panel: Trump sought to pressure FDA on covid vaccines, treatment

Today, House Select Subcommittee on the Coronavirus Crisis reports Trump White House officials coordinated with known conspiracy theorists to pressure FDA to reauthorize a debunked, potentially dangerous treatment and tried to block FDA from issuing key vax guidance before the 2020 election.

The report offers fresh details about those efforts and how they rattled agency officials.

08/22/2022
Congress Investigates Corporate Landlord Eviction Practices

Public data previously showed Ventron filed 2,178 eviction cases during the first 16 months of the pandemic—mostly in metro Atlanta. House Select Subcommittee on the Coronavirus Crisis found that Ventron actually filed 4,401 cases in that time.

The Select Subcommittee continues to investigate fraud in pandemic relief programs to ensure that wrongdoers are held ac...
08/17/2022
Prosecutors Struggle to Catch Up to a Tidal Wave of Pandemic Fraud

The Select Subcommittee continues to investigate fraud in pandemic relief programs to ensure that wrongdoers are held accountable and taxpayer funds are distributed effectively, efficiently, and equitably.

Investigators say there was so much fraud in federal Covid-relief programs that — even after two years of work and hundreds of prosecutions — they’re still just getting started.

The Trump Admin awarded vaccine manufacturer Emergent BioSolutions a $628M contract to produce coronavirus vaccines. But...
08/15/2022

The Trump Admin awarded vaccine manufacturer Emergent BioSolutions a $628M contract to produce coronavirus vaccines. But Emergent’s failure to meet or maintain quality standards has led to the destruction of over 525M vaccine doses.

Congress has extended the statute of limitations for prosecution of fraud against pandemic relief programs from 5 years ...
08/12/2022
Biden signs bills tackling Covid relief fraud into law | CNN Politics

Congress has extended the statute of limitations for prosecution of fraud against pandemic relief programs from 5 years to 10 years.

This extends the timeline prosecutors have to hold those committing pandemic relief fraud accountable.

President Joe Biden signed into law two bipartisan bills on Friday aimed at holding accountable individuals who commit fraud under pandemic relief programs.

Chairs James E. Clyburn and Rep. Carolyn B. Maloney released new evidence showing Emergent BioSolutions' quality failure...
08/11/2022
J&J COVID vaccine factory forced to trash even more doses

Chairs James E. Clyburn and Rep. Carolyn B. Maloney released new evidence showing Emergent BioSolutions' quality failures resulted in the waste of an additional 135M coronavirus vaccine doses, bringing the company’s number of total wasted doses to 525M.

WASHINGTON (AP) — About 135 million more doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday.

Address

Washington D.C., DC
20515

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 10am - 5pm
Sunday 12am - 11pm

Alerts

Be the first to know and let us send you an email when House Select Subcommittee on the Coronavirus Crisis posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos


x

Other Government Organizations in Washington D.C. (show all)

House Committee on Natural Resources GOP House Committee on Financial Services House Republicans House Committee on Education and Labor Republicans Energy & Commerce Committee Republicans Financial Services Committee Republicans Committee on House Administration - Democrats Committee on Education and Labor Law.gov Open World Leadership Center United States Congressman Rep. Abd Temsilciler Meclisi US Congressman Chambre des représentants des États-Unis